Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Attendance
Registration fees
Hotel
Venue
Helpful info
Travel info
Programme
Abstract Submission
Postgraduate Teaching
Nurse Programme
Hands-on
Information for Presenters
In-person Networking
myUEG Community Area
Learn from Leaders
Mentoring
The UEG Night
Let's Meet
Women in GI Networking
Industry Programme
Industry Exhibition
Industry Symposia
Meet the experts sessions
Innovation Hub
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Matthieu Allez
IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY
Matthieu Allez
et al.
IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19
Matthieu Allez
et al.
IL-23p19 inhibitors
Matthieu Allez
Fertility impairment: Medical vs surgical view
Matthieu Allez
COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE
Matthieu Allez
et al.
How to manage postoperative recurrence?
Matthieu Allez
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: PROMIS-29 IN THE SEAVUE STUDY
Early identification of colon cancer: How to do it best?
Matthieu Allez
Which clinical targets have the potential to change the natural course of IBD? (Takeda)
Matthieu Allez
et al.
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Matthieu Allez
et al.
IMPACT OF BIOLOGICS ON THE RISK OF EARLY POSTOPERATIVE COMPLICATIONS IN CROHN'S DISEASE: A FRENCH NATIONWIDE STUDY
Matthieu Allez
et al.
VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL PREDICTS EFFICACY OF VEDOLIZUMAB BUT NOT USTEKINUMAB IN REFRACTORY CROHN'S DISEASE
Matthieu Allez
et al.
MICROBIAL SIGNALS AND HOST SENSING CONTROL METABOLIC INJURY IN THE INTESTINAL EPITHELIUM
Matthieu Allez
et al.
SEVERE GASTRITIS AND DUODENITIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A MULTICENTER STUDY
Matthieu Allez
et al.
METABOLIC INJURY OF THE INTESTINAL EPITHELIUM TRIGGERS DYSBIOTIC EXPANSION OF BACTEROIDES SPP. DRIVING CHRONIC INFLAMMATION
Matthieu Allez
et al.
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
Matthieu Allez
et al.
LONGITUDINAL DYNAMICS OF GUT MICROBIOME AND METABOLOME AFTER BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASES
Matthieu Allez
et al.
HEALTH-RELATED QUALITY OF LIFE WITH USTEKINUMAB VERSUS ADALIMUMAB FOR INDUCTION AND MAINTENANCE THERAPY IN BIOLOGIC-NAÏVE PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: IBDQ IN THE SEAVUE STUDY
Matthieu Allez
et al.
INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL
Matthieu Allez
et al.
Item 1 - 20 / 23
1
2
Chat with us
, powered by
LiveChat